Europa · Agencias y tiempo real · Reuters US Markets

US judge won't block Eli Lilly ads for weight-loss drugs, rules against Novo Nordisk

Publicado por Reuters US Markets · Reino Unido hace 12 h

A US judge on Monday rejected Novo Nordisk's request to block ‌Eli Lilly from continuing weight-loss drug advertisements that the Danish drugmaker considered false and misleading.

Leer el artículo completo en Reuters US Markets Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.reuters.com)

US judge won't block Eli Lilly ads for weight-loss drugs, rules against Novo Nordisk

También te puede interesar

Jordanian airstrikes kill five civilians in southern Syria, officials say

Iraq, Jordan sign 9 cooperation memorandums, programs in education, environment, economy

Anthropic discloses month-long training pause, AI security breaches in IPO filing

AI scaling race accelerates investments in microgrid technology

Natural Field Advances from Functional Ingredients to Delivery Technologies and Science-Based Solutions at SupplySide Global 2026

Correction to CBAM Certificate Index and aluminium extrusion billet premium prices for October 22-23

US judge won't block Eli Lilly ads for weight-loss drugs, rules against Novo Nordisk

Compartir

También te puede interesar

Jordanian airstrikes kill five civilians in southern Syria, officials say

Iraq, Jordan sign 9 cooperation memorandums, programs in education, environment, economy

Anthropic discloses month-long training pause, AI security breaches in IPO filing

AI scaling race accelerates investments in microgrid technology

Natural Field Advances from Functional Ingredients to Delivery Technologies and Science-Based Solutions at SupplySide Global 2026

Correction to CBAM Certificate Index and aluminium extrusion billet premium prices for October 22-23